Susquehanna International Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-88,896
| Closed | -$18K | – | 11084 |
|
|
2018
Q1 | $18K | Buy |
88,896
+36,800
| +71% | +$33.9K | ﹤0.01% | 9139 |
|
|
2017
Q4 | $67K | Buy |
52,096
+27,245
| +110% | +$44.4K | ﹤0.01% | 8835 |
|
|
2017
Q3 | $53K | Sell |
24,851
-11,235
| -31% | -$27.4K | ﹤0.01% | 8528 |
|
|
2017
Q2 | $105K | Sell |
36,086
-11,627
| -24% | -$34.9K | ﹤0.01% | 8669 |
|
|
2017
Q1 | $164K | Sell |
47,713
-102
| -0.2% | -$403 | ﹤0.01% | 8150 |
|
|
2016
Q4 | $83K | Buy |
47,815
+27,672
| +137% | +$65K | ﹤0.01% | 9155 |
|
|
2016
Q3 | $67K | Buy |
20,143
+8,680
| +76% | +$32.8K | ﹤0.01% | 8059 |
|
|
2016
Q2 | $49K | Sell |
11,463
-18,939
| -62% | -$85.6K | ﹤0.01% | 8250 |
|
|
2016
Q1 | $171K | Buy |
30,402
+7,935
| +35% | +$103K | ﹤0.01% | 8108 |
|
|
2015
Q4 | $386K | Sell |
22,467
-67,902
| -75% | -$1.62M | ﹤0.01% | 7248 |
|
|
2015
Q3 | $1.91M | Buy |
90,369
+41,734
| +86% | +$1.43M | ﹤0.01% | 4375 |
|
|
2015
Q2 | $2.41M | Sell |
48,635
-15,652
| -24% | -$936K | ﹤0.01% | 4313 |
|
|
2015
Q1 | $5.03M | Sell |
64,287
-40,292
| -39% | -$2.5M | ﹤0.01% | 2736 |
|
|
2014
Q4 | $6.34M | Buy |
104,579
+21,165
| +25% | +$1.06M | ﹤0.01% | 2554 |
|
|
2014
Q3 | $3.55M | Sell |
83,414
-32,436
| -28% | -$1.74M | ﹤0.01% | 3582 |
|
|
2014
Q2 | $7.16M | Buy |
115,850
+85,131
| +277% | +$4.95M | ﹤0.01% | 2547 |
|
|
2014
Q1 | $2M | Sell |
30,719
-9,146
| -23% | -$619K | ﹤0.01% | 4362 |
|
|
2013
Q4 | $2.25M | Sell |
39,865
-2,785
| -7% | -$156K | ﹤0.01% | 4084 |
|
|
2013
Q3 | $2.62M | Buy |
42,650
+9,068
| +27% | +$614K | ﹤0.01% | 3684 |
|
|
2013
Q2 | $1.97M | Buy |
+33,582
| New | +$2.07M | ﹤0.01% | 3937 |
|
Other funds holding OREX
Susquehanna International Group's OREX Position: Q2 2018 in Review
Susquehanna International Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 88,896 shares — an estimated $18K sold.
Susquehanna International Group first reported a position in OREX in Q2 2013 and held it in 20 quarters. The position peaked at $7.16M in Q2 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Susquehanna International Group reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Susquehanna International Group sold 88,896 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $18K.
- Susquehanna International Group first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 20 quarters.
- Susquehanna International Group's Orexigen Therapeutics, Inc. position peaked at $7.16M in Q2 2014.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.